In a circular to shareholders yesterday, AmInvestment Bank said the offer price of 38 sen is higher than the ascribed equity value of 24 sen to 28 sen per share and represented a premium of 10 sen to 14 sen
PETALING JAYA: Pharmaceutical company Hovid Bhd has received approval for its delisting from the Main Market of Bursa Malaysia.
As such, and together with shareholders’ approval for the proposed withdrawal of its listing statue at an EGM on Nov 26, all conditions for the voluntary takeover have been fulfilled and the offer is now unconditional as at Dec 3.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
